SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

IQVIA Holdings Inc. 
 NC
  SEC # 1478242


        
35  Related Registrants:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

255  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
2/23/24DEF 14A1About the 2024 Annual Meeting
1APPENDIX A Financial Reconciliations
1Audit
1Audit Committee Report
1Back to Contents
1Base Salary
1Benchmarking
1Board Evaluation Process
1Board of Directors
1Board's Role in Risk Oversight
2/15/2410-K1Business
2/23/24DEF 14A1Cautionary Note Regarding Forward-Looking Statements
1/25/24424B31Cautionary Statement Regarding Forward-Looking Information
2/23/24DEF 14A1CEO Pay Ratio
1Certain Relationships and Related Person Transactions
2/15/2410-K1Certain Relationships and Related Transactions and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
2/23/24DEF 14A1Clawback Policies
1Commitment to Public Health
1Compensation and Governance Practices
1Compensation Committee Interlocks and Insider Participation
1Compensation Discussion and Analysis
1Compensation of Named Executive Officers
1Compensation of Our Chief Executive Officer
1Compensation Philosophy
8/1/2310-Q1Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022
4/28/2310-Q1Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022
11/1/2310-Q1Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022
1Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022
8/1/2310-Q1Condensed Consolidated Statements of Cash Flows for the six months ended
4/28/2310-Q1Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022
11/1/2310-Q1Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2023 and 2022
8/1/2310-Q1Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2023 and 2022
4/28/2310-Q1Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2023 and 2022
11/1/2310-Q1Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2023 and 2022
8/1/2310-Q1Condensed Consolidated Statements of Income for the three and six months ended June 30, 2023 and 2022
4/28/2310-Q1Condensed Consolidated Statements of Income for the three months ended March 31, 2023 and 2022
11/1/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2023 and 2022
8/1/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended June 30, 2023 and 2022
4/28/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2023 and 2022
2/15/2410-K1Controls and Procedures
2/23/24DEF 14A1Corporate Governance
1Corporate Governance Enhancements
1Corporate Governance Highlights
2/15/2410-K1Cybersecurity
1/25/24424B31Description of the Registered Notes
2/23/24DEF 14A1Director Compensation
2/15/2410-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
2/23/24DEF 14A1Documents Establishing Our Corporate Governance
1Elements of Compensation
1Elements of Our Executive Compensation Program
1Enhancements to our Executive Compensation Program Based on Investor Feedback
2/15/2410-K1Executive Compensation
2/23/24DEF 14A1Executive Compensation Practices Highlights
1Executive Summary
2/15/2410-K1Exhibit Index
11/1/2310-Q1Exhibits
2/15/2410-K1Exhibits and Financial Statement Schedules
1/25/24424B31Experts
2/23/24DEF 14A1Fees Paid to Independent Registered Public Accounting Firm
11/1/2310-Q1Financial Statements (unaudited)
2/15/2410-K1Financial Statements and Supplementary Data
1Form 10-K Summary
2/23/24DEF 14A1How to Contact the Board and its Committees
1IMS Health Defined Benefit Retirement Plans
1Incorporation by Reference
1IQVIA's Statement in Opposition
11/1/2310-Q1Item 1
1Item 1A
1Item 2
1Item 3
1Item 4
1Item 6
8/1/2310-Q1June
2/23/24DEF 14A1Key Features to Align Executive Pay with Stockholder Interests
1Leadership Development and Compensation Committee Report
1Leadership Structure
1/25/24424B31Legal Matters
2/15/2410-K1Legal Proceedings
2/23/24DEF 14A1Long-Term Incentive Awards
2/15/2410-K1Management's Discussion and Analysis of Financial Condition and Results of Operations
1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
1/25/24424B31Material U.S. Federal Income Tax Considerations
2/23/24DEF 14A1Meetings and Executive Sessions
2/15/2410-K1Mine Safety Disclosures
2/23/24DEF 14A1Named Executive Officer Compensation at a Glance
1Non-Employee Director Compensation Program
11/1/2310-Q1Notes to Condensed Consolidated Financial Statements
2/15/2410-K1Other Information
2/23/24DEF 14A1Other Matters
1Other Relevant Information
1Outstanding Equity Awards at Fiscal Year-End for 2023
1Overview of Our Executive Compensation Program
1Overview of Russian Operations
2/15/2410-K1Part I
11/1/2310-Q1Part I-Financial Information
2/15/2410-K1Part Ii
11/1/2310-Q1Part Ii-Other Information
2/15/2410-K1Part Iii
1Part Iv
2/23/24DEF 14A1Pay versus Performance
1/25/24424B31Plan of Distribution
2/23/24DEF 14A1Potential Payments Upon Termination or Change in Control
1/5/24S-41Powers of Attorney (included on the signatures page hereto)
2/15/2410-K1Principal Accountant Fees and Services
1Properties
2/23/24DEF 14A1PROPOSAL NO. 1 Election of Directors
1PROPOSAL NO. 2 Advisory Non-Binding Vote on Executive Compensation
1PROPOSAL NO. 3 Stockholder Proposal: Transparency in Political Spending
1PROPOSAL NO. 4 Ratification of the Appointment of the Independent Registered Public Accounting Firm
1Proxy Statement Summary
2/15/2410-K1Quantitative and Qualitative Disclosures About Market Risk
2/23/24DEF 14A1Related Party Transactions Approval Policy
2/15/2410-K1Reserved
2/23/24DEF 14A1Retirement, Perquisites and Termination Benefits
1Rigorous Accountability, Risk-Mitigation and Recovery Provisions
1Risk Assessment
2/15/2410-K1Risk Factors
2/23/24DEF 14A1Roles of the LDC Committee, Board and Management in Compensation Decisions
1Say-on-Pay
1Security Ownership of Certain Beneficial Owners and Management
2/15/2410-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
2/23/24DEF 14A1Share Ownership Guidelines
1Short-Term Incentive Awards
2/15/2410-K1Signatures
2/23/24DEF 14A1Stockholder Engagement
1Stockholder Proposals and Nominees for 2025 Annual Meeting of Stockholders
1/25/24424B31Summary
2/23/24DEF 14A1Sustainability
1Sustainability Highlights
1/25/24424B31Table of Contents
2/23/24DEF 14A1Tax Deductibility
1/25/24424B31Terms of the Exchange Offer; Registration Rights
11/1/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
2/15/2410-K1Unresolved Staff Comments
2/23/24DEF 14A1Use of Compensation Consultant
1Use of Non-GAAP Financial Measures
1/25/24424B31Use of Proceeds
1Where You Can Find More Information
2/23/24DEF 14A1103
1104
1105
1106
1108
1111
1112
2/15/2410-K1115
2/23/24DEF 14A1116
1117
2/15/2410-K1118
2/23/24DEF 14A1119
1120
1121
1122
1124
1125
2/15/2410-K1126
2/23/24DEF 14A1130
1131
1133
8/1/2310-Q12023 and 2022
2/23/24DEF 14A12023 Base Salary
12023 Business Performance Highlights
12023 Compensation Determinations
12023 Grants of Plan-Based Awards
12023 Long-Term Incentive Awards
12023 Named Executive Officers
12023 Non-Qualified Deferred Compensation
12023 Option Exercises and Stock Vested
12023 Pension Benefits
12023 Short-Term Incentive Awards
12023 Summary Compensation Table

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 9:45:14.2pm ET